Annual Current Liabilities
$30.31 M
+$19.29 M+174.97%
30 June 2024
Summary:
Renovaro Biosciences annual total current liabilities is currently $30.31 million, with the most recent change of +$19.29 million (+174.97%) on 30 June 2024. During the last 3 years, it has risen by +$28.42 million (+1507.18%). RENB annual current liabilities is now at all-time high.RENB Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$23.04 M
-$7.27 M-24.00%
30 September 2024
Summary:
Renovaro Biosciences quarterly total current liabilities is currently $23.04 million, with the most recent change of -$7.27 million (-24.00%) on 30 September 2024. Over the past year, it has increased by +$9.28 million (+67.43%). RENB quarterly current liabilities is now -24.00% below its all-time high of $30.31 million, reached on 30 June 2024.RENB Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RENB Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +175.0% | +67.4% |
| 3 y3 years | +1507.2% | +271.4% |
| 5 y5 years | +2629.6% | +2013.2% |
RENB Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +1507.2% | -24.0% | +271.4% |
| 5 y | 5 years | at high | +2629.6% | -24.0% | +2668.0% |
| alltime | all time | at high | >+9999.0% | -24.0% | >+9999.0% |
Renovaro Biosciences Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $23.04 M(-24.0%) |
| June 2024 | $30.31 M(+175.0%) | $30.31 M(+45.2%) |
| Mar 2024 | - | $20.87 M(+51.7%) |
| Dec 2023 | - | $13.76 M(+36.3%) |
| Sept 2023 | - | $10.10 M(-8.4%) |
| June 2023 | $11.02 M(+70.9%) | - |
| June 2023 | - | $11.02 M(-6.4%) |
| Mar 2023 | - | $11.77 M(+4.3%) |
| Dec 2022 | - | $11.29 M(+57.7%) |
| Sept 2022 | - | $7.16 M(+11.0%) |
| June 2022 | $6.45 M(+242.1%) | $6.45 M(-14.1%) |
| Mar 2022 | - | $7.51 M(+21.1%) |
| Dec 2021 | - | $6.20 M(+412.4%) |
| Sept 2021 | - | $1.21 M(-35.8%) |
| June 2021 | $1.89 M(+41.3%) | $1.89 M(+33.9%) |
| Mar 2021 | - | $1.41 M(-9.6%) |
| Dec 2020 | - | $1.56 M(+87.3%) |
| Sept 2020 | - | $832.20 K(-37.7%) |
| June 2020 | $1.33 M(+20.2%) | $1.33 M(+37.4%) |
| Mar 2020 | - | $971.30 K(-10.9%) |
| Dec 2019 | - | $1.09 M(-16.2%) |
| Sept 2019 | - | $1.30 M(+17.2%) |
| June 2019 | $1.11 M(+27.1%) | $1.11 M(-26.9%) |
| Mar 2019 | - | $1.52 M(-7.3%) |
| Dec 2018 | - | $1.64 M(+108.7%) |
| Sept 2018 | - | $784.90 K(-10.2%) |
| June 2018 | $873.70 K | $873.70 K(-3.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | $906.10 K(-84.8%) |
| Dec 2017 | - | $5.97 M(+528.0%) |
| Sept 2017 | - | $951.40 K(-68.2%) |
| June 2017 | $2.99 M(+98.2%) | $2.99 M(+50.3%) |
| Mar 2017 | - | $1.99 M(+41.5%) |
| Dec 2016 | - | $1.41 M(-0.3%) |
| Sept 2016 | - | $1.41 M(-6.5%) |
| June 2016 | $1.51 M(+51.5%) | $1.51 M(+44.5%) |
| Mar 2016 | - | $1.04 M(+16.8%) |
| Dec 2015 | - | $893.90 K(-11.8%) |
| Sept 2015 | - | $1.01 M(+4.3%) |
| June 2015 | $995.70 K(-43.4%) | - |
| Mar 2015 | - | $972.00 K(-44.7%) |
| Dec 2014 | $1.76 M(+2368.7%) | $1.76 M(-64.4%) |
| Sept 2014 | - | $4.93 M(+47.3%) |
| June 2014 | - | $3.35 M(+8.1%) |
| Mar 2014 | - | $3.10 M(+3806.2%) |
| Dec 2013 | - | $79.30 K(-5.4%) |
| Sept 2013 | - | $83.80 K(+24.0%) |
| June 2013 | - | $67.60 K(-5.1%) |
| Mar 2013 | $71.20 K(+161.8%) | $71.20 K(+29.7%) |
| Dec 2012 | - | $54.90 K(+16.1%) |
| Sept 2012 | - | $47.30 K(+23.8%) |
| June 2012 | - | $38.20 K(+40.4%) |
| Mar 2012 | $27.20 K(+212.6%) | $27.20 K(+20.4%) |
| Dec 2011 | - | $22.60 K |
| Mar 2011 | $8700.00 | - |
FAQ
- What is Renovaro Biosciences annual total current liabilities?
- What is the all time high annual current liabilities for Renovaro Biosciences?
- What is Renovaro Biosciences annual current liabilities year-on-year change?
- What is Renovaro Biosciences quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Renovaro Biosciences?
- What is Renovaro Biosciences quarterly current liabilities year-on-year change?
What is Renovaro Biosciences annual total current liabilities?
The current annual current liabilities of RENB is $30.31 M
What is the all time high annual current liabilities for Renovaro Biosciences?
Renovaro Biosciences all-time high annual total current liabilities is $30.31 M
What is Renovaro Biosciences annual current liabilities year-on-year change?
Over the past year, RENB annual total current liabilities has changed by +$19.29 M (+174.97%)
What is Renovaro Biosciences quarterly total current liabilities?
The current quarterly current liabilities of RENB is $23.04 M
What is the all time high quarterly current liabilities for Renovaro Biosciences?
Renovaro Biosciences all-time high quarterly total current liabilities is $30.31 M
What is Renovaro Biosciences quarterly current liabilities year-on-year change?
Over the past year, RENB quarterly total current liabilities has changed by +$9.28 M (+67.43%)